An antibody-interleukin 2 fusion protein overcomes tumor heterogeneity by induction of a cellular immune response.

Схожие документы

• Long-lived and transferable tumor immunity in mice after targeted interleukin-2 therapy.
  по: Becker, J C, et al.
  Опубликовано: (1996)
• Eradication of human hepatic and pulmonary melanoma metastases in SCID mice by antibody-interleukin 2 fusion proteins.
  по: Becker, J C, et al.
  Опубликовано: (1996)
• Antibody-targeted interleukin 2 stimulates T-cell killing of autologous tumor cells.
  по: Gillies, S D, et al.
  Опубликовано: (1992)
• A recombinant antibody-interleukin 2 fusion protein suppresses growth of hepatic human neuroblastoma metastases in severe combined immunodeficiency mice.
  по: Sabzevari, H, et al.
  Опубликовано: (1994)
• Possible role of anti-idiotypic antibodies in the induction of tumor immunity.
  по: Kennedy, R C, et al.
  Опубликовано: (1987)